Evidence map›Paper›PMID 32913238›Full record

ArticleScientific reports2020

Reconfigurable honeycomb metamaterial absorber having incident angular stability.

Javad Shabanpour, Sina Beyraghi, Homayoon Oraizi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.1field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Javad ShabanpourDepartment of Electrical Engineering, Iran University of Science and Technology, Narmak, Tehran, 16486-13114, Iran. m.javadshabanpour1372@gmail.com.
Sina BeyraghiDepartment of Electrical Engineering, Iran University of Science and Technology, Narmak, Tehran, 16486-13114, Iran.
Homayoon OraiziDepartment of Electrical Engineering, Iran University of Science and Technology, Narmak, Tehran, 16486-13114, Iran.
Iran University of Science and Technology · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultrawide-angle electromagnetic wave absorbers with excellent mechanical properties are required in many diverse applications such as sensing, and stealth technologies. Here, a novel 3D reconfigurable metamaterial absorber (MMA) consisting of honeycomb and VO2 films is proposed. The proposed MMA exhibits a strong absorptivity above 90% in the widest incident angle up to [Formula: see text] for TM- and TE polarized oblique incidences for THz wave propagating in yoz-plane. Under normal incidence, when VO2 films are in the insulating state, the proposed absorber exhibits high absorptivity in the frequency band of 1-4 THz. By increasing the temperature of the whole structure, the structural transformation of VO2 occurs and turns into the metallic phase. We have shown that under oblique incidence, the ohmic losses of VO2 films especially those parallel to the direction of the incident electric field are the most important absorption principles of the proposed MMA. Due to the ultra wide-angle absorption (angular stability) and mechanical performance, it is expected that the presented MMA may find potential applications, such as camouflage technologies, electromagnetic interference, imaging, and sensing. To the best knowledge of authors, the proposed MMA configuration exhibits the absorptivity in the widest incident angle ever reported.

Identifiers

PMID32913238
PMCPMC7483420
OpenAlexW3039471083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.